Company Filing History:
Years Active: 2021
Title: **Yuting Tan: Innovator in Biopharmaceuticals from Chengdu, China**
Introduction
Yuting Tan is an accomplished inventor based in Chengdu, China, recognized for her significant contributions in the field of biopharmaceuticals. With two patents to her name, she is at the forefront of innovative research that aims to tackle complex health issues.
Latest Patents
Yuting's recent patents reflect her innovative spirit and dedication to improving medical treatments. Her first patent, titled "Polyamide compound and use thereof," involves a polyamide compound designed to prevent or treat diseases associated with the k-opioid receptor. This groundbreaking invention boasts excellent k-opioid receptor agonistic activity and enhanced safety features, offering lower toxicity and fewer side effects for patients.
Her second patent, "Nucleoside phosphate compound and preparation method and use thereof," introduces a compound that serves as an NS5B polymerase inhibitor, a DNA polymerase inhibitor, or a reverse transcriptase inhibitor. This invention demonstrates significant potential for the prevention or treatment of viral diseases and certain cancers, showcasing Yuting's commitment to advancing healthcare solutions.
Career Highlights
Yuting Tan is affiliated with Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd., a company renowned for its focus on biopharmaceutical innovation. Throughout her career, Yuting has dedicated herself to developing novel compounds that provide effective treatment options while prioritizing patient safety and well-being.
Collaborations
Yuting has collaborated with prominent colleagues such as Jiaqiang Cai and Qiang Tian. These partnerships not only enhance her research capabilities but also foster a creative environment that encourages innovation within the biopharmaceutical field.
Conclusion
Yuting Tan stands out as a leading figure in biopharmaceutical innovation, with her work aimed at improving treatment outcomes for various diseases. Her two patents highlight her commitment to science and medicine, positioning her as a valuable contributor to the future of healthcare.